AMGN


Amgen Issues Green Bond for The First Time

This article was originally published on TipRanks.com Biopharmaceutical company Amgen Inc.

What Do Amgen’s Newly Added Risk Factors Reveal?

This article was originally published on TipRanks.com Amgen (AMGN) is an American multinational drug company.

Amgen Reports Mixed Q4 Results

This article was originally published on TipRanks.com Biopharmaceutical company Amgen Inc.

Japan Approves Amgen’s LUMAKRAS

This article was originally published on TipRanks.com Amgen (NASDAQ: AMGN), an American multinational biopharmaceutical company, announced that Japan has approved LUMAKRAS (sotorasib), the first-of-its-kind KRAS G12C inhibitor.

Analyzing Amgen’s Newly Added Risk Factors

This article was originally published on TipRanks.com Amgen (AMGN) is a global biopharmaceutical company based in California.

Amgen Bags FDA Approval for Tezspire to Treat Severe Asthma

This article was originally published on TipRanks.com Biopharmaceutical company Amgen Inc.

Amgen Bumps up Quarterly Dividend by 10%

This article was originally published on TipRanks.com Amgen (AMGN) has raised its quarterly cash dividend by 10% to $1.

Amgen Reveals Topline Results from Otezla Phase 3 DISCREET Study

This article was originally published on TipRanks.com Amgen (AMGN) has revealed positive topline results from the Phase 3 DISCREET trial.

Amgen Starts Construction on New Biomanufacturing Unit in Ohio

Amgen, Inc. (AMGN) revealed that it has started construction on its new biomanufacturing plant in Ohio.

Amgen’s Q3 Results Outperform; Shares Drop on Mixed 2021 Outlook

Amgen (AMGN) has reported robust third-quarter 2021 results, which surpassed both earnings and revenue estimates. Shares of the biotechnology company, however, slipped 1.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts